Schedule 13G ownership disclosure

EAGLE PHARMACEUTICALS INC

Common Stock · CUSIP: 269796108

Event date: 2025-06-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • J. Goldman & Co LP

    Shares: 667,108.00 · Class: 5.1%

  • J. Goldman Capital Management, Inc.

    Shares: 667,108.00 · Class: 5.1%

  • GOLDMAN JAY G

    Shares: 667,108.00 · Class: 5.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001412741-25-000006
Form type
SCHEDULE 13G
Filer
EAGLE PHARMACEUTICALS, INC.
CIK
CIK 827871
Filed
Aug 14, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub